• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NSB 9.09% 5.0¢

NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD

NeuroScientific Biopharmaceuticals Limited is an Australia-based company that is engaged... NeuroScientific Biopharmaceuticals Limited is an Australia-based company that is engaged in developing peptide-based pharmaceutical drugs that target a number of neurodegenerative conditions with high unmet medical demand. The Company’s product portfolio includes EmtinB, a therapeutic peptide initially targeting Alzheimer’s disease and glaucoma, as well as other Emtin peptides (EmtinAc, EmtinAn, and EmtinBn), which have demonstrated similar therapeutic potential as EmtinB. EmtinB is a peptide-based compound that binds to surface-based cell receptors from the LDLR family, activating intracellular signalling pathways that stimulate neuroprotection, neuroregeneration and modulate neuroinflammation. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-IIA, which is produced as part of the human body’s innate immune response to cell injury. More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NSB
NSB Charts
2 3 4
05/05/24 208 58K
05/05/24 Last post  ectoplasm Comments Created with Sketch.  208  Views Created with Sketch.  58K 
NSB 29/04/24 2 550
29/04/24 Last post  the_contrarian Comments Created with Sketch.  2  Views Created with Sketch.  550 
NSB
emtinb close to glaucoma nerve cure
26/04/24 3 867
26/04/24 Last post  TopGun1 Comments Created with Sketch.  3  Views Created with Sketch.  867 
NSB 22/04/24 28 8.9K
22/04/24 Last post  ozz1 Comments Created with Sketch.  28  Views Created with Sketch.  8.9K 
NSB 19/04/24 28 7.0K
19/04/24 Last post  ozz1 Comments Created with Sketch.  28  Views Created with Sketch.  7.0K 
NSB 08/04/24 0 240
08/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  240 
NSB 07/04/24 23 4.3K
07/04/24 Last post  tuts Comments Created with Sketch.  23  Views Created with Sketch.  4.3K 
NSB 26/03/24 15 3.8K
26/03/24 Last post  TopGun1 Comments Created with Sketch.  15  Views Created with Sketch.  3.8K 

See All Discussions arrow Created with Sketch.

Timeline

Quarterly Activities/Appendix 4C Cash Flow Report
29 Apr 08:52
 
Notification of cessation of securities - NSB
08 Apr 12:04
 
Appointment of Executive Director & FDA Pre-Ind Meeting
02 Apr 09:26
 
NSB Receives A$2.2M Research & Development Tax Refund
20 Mar 09:39
 
Half Yearly Report and Accounts
27 Feb 17:43
 
Company Secretary Appointment/Resignation
06 Feb 09:52
 
View More arrow Created with Sketch.
(20min delay)
Last
5.0¢
Change
-0.005(9.09%)
Mkt cap ! $7.23M
Open High Low Value Volume
5.2¢ 5.3¢ 4.8¢ $11.88K 243.3K

Buyers (Bids)

No. Vol. Price($)
1 10000 4.8¢
 

Sellers (Offers)

Price($) Vol. No.
5.1¢ 12068 1
View Market Depth
Last trade - 13.00pm 06/05/2024 (20 minute delay) ?
Last
5.3¢
  Change
-0.005 ( 0.00 %)
Open High Low Volume
5.3¢ 5.3¢ 5.3¢ 257
Last updated 10.57am 06/05/2024 ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.